Tasman Therapeutics to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

SAN FRANCISCO, April 22, 2026 /PRNewswire/ -- Tasman Therapeutics, a biotechnology company developing novel treatments for patients with hard-to-treat mood disorders, announced today that CEO Dan Browne will participate in a panel entitled "Reimagining Ketamine Delivery for Scale" at the...